Introduction
Chronic osteomyelitis, a serious clinical disease, usually results in substantial disability. The abuse of antibiotics and cross infection in hospital aggravated the occurrence of chronic osteomyelitis. The most common resistant strains are methicillin-resistant Staphylococcus aureus (MRSA). Following the emergence of
Characterization of materials
The structural morphology of SF-AgNPs was observed under 10 kV accelerating voltage. Before imaging, the sample was sputter coated with gold under vacuum. The EDX energy-dispersive spectrometer attached to SEM could detect trace chemical elements in materials synchronously.
The crystal structure of the scaffold material was detected by XRD. The diffraction source was copper target (Cu, Ka ¼ 1.54056 Å ). The scanning region was 2u ¼ 5-608; the voltage 40 kV; the current 300 mA and the scanning rate 0.68 min 21 .
The interactions and functional groups between SF and AgNPs were evaluated using FTIR. The samples were fully ground and thoroughly mixed with KBr and then assessed in the IR spectra of 400 to 4000 cm 21 at room temperature.
Biocompatibility of SF-AgNPs and osteoblasts (MC-3T3)
The human osteoblast-like cell line MC-3T3 cell was selected for compatibility with SF-AgNPs materials. The cell was cultured in DMEM supplemented with 10% FBS. The materials were cut into a circle with 10 mm diameter and 5 mm thickness and sterilized by ultraviolet before the test.
First, we used CLSM to observe the distribution and morphological characteristics of MC-3T3 cells on the materials. The cells were cultured on materials for 5 days, then the cells and material samples were fixed with 4% polyformaldehyde for 15 min. After washing with PBS three times, the cells were stained with DAPI for nuclear fluorescent dye and FITC-phalloidin for F-actin cytoskeleton. After two times of ddH 2 O washing, the cover glass was placed under the laser confocal microscope to observe and photograph.
According to ISO 10993-5, the cytotoxicity of materials could be detected by the indirect test. Briefly, the materials were soaked in 1 ml of culture medium and incubated at 378C for 1, 4, 7 and 10 days, and the supernatant was then extracted for detection. Afterwards, 500 ml cell suspension with a density of 5 Â 10 4 ml 21 were seeded onto a 96-well plate for 3 days. Next, the medium was replaced with the extracted supernatant and cultured for 24 h at 378C. Subsequently, the cell count kit-8 assay and ALP/Runx2 activity were performed.
The CCK-8 assay was used to detect the viability and proliferation of MC-3T3 cell. Twenty microlitres of CCK-8 plus 500 ml DMEM was replaced to each well for 4 h at 378C. Subsequently, the 300 ml supernatant per well was transferred to new 96-well plates, and the absorbance value was measured using the microplate reader at 450 nm. ALP/Runx2 activity was tested by the ELISA kit. Briefly, the 0.05% TritonX-100 cell lysate was added for 12 h at 48C. Finally, according to the manufacturer's protocol of the kit, 20 ml of the suspension was added into the ALP and Runx2 kits in turn. The absorbance was measured at 410 nm.
Antibacterial test
In this study, the MRSA strain selected was ATCC43300. Kirby -Bauer disc diffusion method was used to evaluate the antimicrobial susceptibility of SF-AgNPs materials. Briefly, 100 ml of bacterial suspension was smeared on Mueller Hinton agar plates according to the density of 10 5 -10 6 CFU ml 21 . The samples of different materials (10 mm diameter and 5 mm thickness) were evenly placed in the incubator for 24 h at 378C. The zone of inhibition was measured three times.
The growth curve method was used to detect the effect of materials on bacterial proliferation. The 50 mg samples of different materials were placed in the flask with 50 ml PBS. Then 5 ml MRSA bacteria solution at a density of 10 5 ml 21 was added, then sealed and cultured on the shaking table at 378C for 24 h. The 50 ml suspension was collected every 2 h and the colony-forming units were counted after dilution. Bacterial suspension without material was used as a blank control group. The number of colonies at each time point was recorded and the inhibition of bacterial rate curve was drawn.
Inhibition of bacterial rate ð%Þ ¼
where C b is the number of culture colonies in the blank control and C s is the number of cultured colonies in the sample.
In vivo osteomyelitis rat model and surgical procedures
According to the results of in vitro compatibility and antibacterial activity, we selected 0.5% of AgNPs in SF scaffolds as a scaffold material for in vivo studies. Gentamicin combined with scaffold materials was used to treat osteomyelitis in rat models. Pure SF scaffolds and gentamicin combined with SF were used as controls. Male Wistar rats (260-280 g) were chosen for animal studies. The osteomyelitis model was made as follows: the animals were successfully anaesthetized with Ketamine (60 mg kg 21 ) and Xylazin (3 mg kg 21 ). The proximal tibia was prepared, the limbs were fixed on the operating table, the right proximal tibia was cut through the lateral longitudinal incision, the skin and the surrounding tissue were cut into the tibia and the tibial plateau was exposed. The bone-piercing holes and openings were perforated with the puncture needle in the middle of the plateau. A 2 mm Kirschner needle expanded the hole and opened the bone marrow cavity, then injected into the bone marrow cavity with 5% sodium hyaluronate 0.1 ml and 1 Â 10 8 CFU ml 21 MRSA liquid 0.1 ml. The bone wax was closed to the hole, and the wound was sutured after the saline was washed three times. Antibiotics were not used during and after the operation. One week after the operation, the rats were anesthetized again on the operating table, and the original incision was dissected to re-expose the drilling holes of the tibial plateau. Debridement was performed on the affected limbs and rinsed with saline three times, then the steel brushes and dental burrs were used to eliminate necrotic and infected tissues repeatedly, and rinsed three times with saline again. The blank control group (a) did not have anything placed after debridement (n ¼ 5), and the experimental group was implanted with various scaffolds: (b) SF (n ¼ 6); (c) SF-AgNPs (n ¼ 6); (d) SF þ Gentamicin (n ¼ 6); (e) SF-AgNPs þ Gentamicin (n ¼ 6). The wound was cleaned and the incision was closed. Routine feeding was done after the operation. Three weeks after the operation, the rats were sacrificed and bone specimens were taken.
At the time point (the day before osteomyelitis model, the day before surgery, one, two and three weeks after the surgery), the weight of the rats was measured and the white blood cell (WBC) count was detected by the extraction of the caudal vein.
At three weeks after the operation, the X-ray images of the affected limbs were performed. After the integrated tibia was dissected and weighed, the specific infected bone tissues of the tibia upper one-third segment were stained with haematoxylin eosin (HE). Four percent paraformaldehyde was fixed, decalcified and embedded in sections and observed under a microscope.
The remaining part of the tibia was ground and crushed into 10 ml PBS flask, which was flushed with a frequency 1200 r.p.m. for 5 min. The suspension was diluted from 10 2 to 10 5 , and then colony forming units were counted. Finally, the concentration of bacteria contained in each gram bone was analysed statistically. Figure 1b shows the general morphologies of SF three-dimensional scaffolds with different contents of AgNPs. The scaffolds turned yellow gradually with the increasing amount of AgNPs. All the scaffolds showed homogeneous porous structure with the pore size of about 130-460 mm. Although small AgNPs clusters appeared occasionally in the scaffolds with Ag concentration of 0.5% and 1% (figure 2a), the EDS spectra indicated the homogeneous distribution of Ag element inside the scaffolds (figure 2b). All XRD patterns of the scaffolds showed three typical characteristic peaks at 2u ¼ 9.6, 2u ¼ 20.68and 2u ¼ 24.18, corresponding to the crystal structure of silk II. The results indicated that the introduction of AgNPs had a negligible effect on the transformation of SF in the salt-leaching process, which was similar to the previous report [12] . The FTIR spectra confirmed the stable silk II structure inside all the scaffolds. Two typical peaks at 1618 and 1512 cm 21 were observed, which corresponded to silk II structure in amide I and II area ( figure 3) . figure 4a-d) showed the morphology of the osteoblasts cultured on the different scaffolds. After being cultured for 5 days, the cells adhered on the porous scaffolds with elongated morphology, suggesting good cell compatibility of the scaffolds. The viability and function of the cells cultured on the scaffolds were evaluated with CCK-8 assay and ELISA kit (figure 4e-g). The survival rate of the cells remained above 90% when cultured using scaffolds soaked in culture medium for 10 days, confirming the low cell cytotoxicity of the scaffolds. Although slight inhibition of cell proliferation appeared in the scaffolds with 1% of AgNPs, the cells showed similar growth behaviour on the scaffolds with 0.1% and 0.5% of AgNPs to that on the pure SF scaffolds. The ALP and Runx2 Protein ELISA tests (figure 4f,g) further confirmed the negligible effect of AgNPs on the cellular functions in the concentration of 0.1 and 0.5%. All the in vitro results indicated acceptable biocompatibility of the composite scaffolds for the treatment of osteomyelitis in vivo.
Results

Characterization of SF-AgNPs
Antimicrobial activity
The introduction of the AgNPs endowed the SF scaffolds with good antimicrobial activity. Compared to pure SF scaffolds, the inhibition rate of the scaffolds increased from 51.8% to 72.3% and 77.5% when the Ag concentration was 0.1%, 0.5% and 1%, respectively. Considering suitable antimicrobial activity and better cell compatibility, the scaffolds with 0.5% of AgNPs were used in rat models figure 5. 
. General
After the chronic osteomyelitis model formation, the rats without scaffold treatment lost their weight slightly with a significant increase in the WBC. After the debridement and scaffold implantation, the rats restored their normal weights and normal amount of the white blood cells (figure 6a,b ).
Radiology
Significant soft tissue swelling happened for the blank control and the rats implanted with Ag-free SF scaffold. X-ray showed extensive osteolytic cavity, reduced bone mineral density, destruction of cortical bone and dead bone formation for the two samples (figure 7a,b) . Different to the control, Figure 6 . The change of body weight (a) and white blood cell (b) count at the day before osteomyelitis model, the day before surgery, and one, two and three weeks after the surgery. 
Histology
Histological sections of blank control group and the Ag-free SF implantation group (figure 7f,g) illustrated significant inflammatory infiltration, abscess formation, osteocyte necrosis, apoptosis and a large number of neutrophils and macrophages, suggesting severe inflammation. When treated with SF-AgNPscomposed scaffolds, the inflammation and abscess significantly alleviated. Only a small amount of inflammatory cell infiltration and periosteal reaction were observed (figure 7h). The introduction of gentamicin further restrained the inflammation and induced neovascularization (figure 7i,j). The inflammatory cells disappeared completely, accompanied by new trabecular bone formation.
Microbiology
After three weeks of implantation, the colony count of the affected limb was counted ( figure 8 ). The bacterial amount in the SF-AgNPs group (6.16 Â 10 5 CFU g 21 ) was significantly lower than that in the blank control group (5.14 Â 10 6 CFU g 21 ) and Ag-free SF scaffold group (5.85 Â 10 6 CFU g 21 ) (p , 0.01), indicating that the loading of the AgNPs significantly inhibited the growth of MRSA bacteria in osteomyelitis. The bacterial amount was further restrained following the introduction of gentamicin, where the bacterial values for the gentamicin-loaded SF and SF-AgNPs þ Gentamicin groups decreased to 4 Â 10 3 and 3.5 Â 10 3 CFU g 21 , respectively. Three of the six cases in SF þ Gentamicin group and four of the six cases in SF-AgNPs þ Gentamicin group inhibited the bacterial growth completely.
Discussion
As antimicrobial agents, silver ions exhibited high efficiency, broad-spectrum activity and non-drug resistance. Silver ions had been used to treat chronic osteomyelitis for over 40 years [13] , but the toxicity of silver ions to tissues limited their clinical applications. The emergence of AgNPs opened the possibility of silver antibacterial materials in the treatment of osteomyelitis. Different biological scaffolds such as L-polylactic acid, chitosan, calcium alginate and acrylic bone cement, were used to load AgNPs to treat periprosthetic infection and osteomyelitis [14 -16] .
In our study, a facile one-pot approach was developed to construct porous SF scaffold containing AgNPs, which was superior to previous two-step process where Ag nanoparticles were synthesized and dispersed into the polymer solution [17, 18] . The reduction of reducing agent and time as well as better dispersion of AgNPs in the matrices offered the scaffold promising future in different applications [19, 20] . Here, FA and SF were used as reducing agents, solvents and matrices simultaneously. SF was also used to stabilize and disperse the formed AgNPs in FA solvent, resulting in homogeneous dispersion of AgNPs in the matrix. Compared to silver ions, the AgNPs show better physico-chemical stability, super sterilizing and extremely low biotoxicity due to their quantum, small size effect and maximum specific surface area [21] . The antibacterial activity of AgNPs came from direct destruction of biofilm structure, inhibition of bacterial DNA replication, interruption of intracellular signal transduction, inhibition of dehydrogenase activity in the respiratory chain and the production of oxygen free radicals [22 -24] . Besides the direct killing effect on bacteria, viruses and fungi, AgNPs could also influence immunomodulatory function [25 -28] . Therefore, AgNPs could eliminate multiple pathogenic microorganisms, especially MRSA without the production of new resistant strains. Our in vivo and in vitro assays confirmed the broad-spectrum bactericidal effect of AgNPs, which was similar to the previous studies [29 -32] .
Local drug and antimicrobial agent delivery was an effective method of improving the curative effect and reducing the recurrence rate of chronic osteomyelitis. As a suitable candidate for bone tissue engineering, SF protein not only facilitated the growth and differentiation of various cells, such as osteoblasts, bone marrow mesenchymal stem cells and adipose stem cells but also stimulated angiogenesis and bone regeneration. However, enhancing the antibacterial activity of SF material remained a key issue. The loading of AgNPs in biomaterials was a feasible option. Considering the dose-dependence of antibacterial activity for AgNPs, choosing a suitable concentration of the AgNPs was critical for medical applications. Here, the preferable concentration of AgNPs in our study remained 0.5%.
In vivo osteomyelitis model confirmed that the loading of AgNPs significantly inhibited the proliferation of MRSA bacteria without the compromise of the advantages of SF materials. Further study was necessary to clarify antibacterial behaviours of AgNPs in osteomyelitis model, especially the effect of AgNPs release behaviour on bacteria in vitro and in vivo. Although our present results verified the possibility of SF-AgNPs material as filling scaffolds and drug delivery carriers simultaneously to treat chronic osteomyelitis, further improvement was required for better therapeutic effect. Optimizing long-term antibacterial properties of the present system was preferred for osteomyelitis. Additional cross-linking of gentamicin on SF scaffolds could increase the sustainedrelease behaviour, which would realize in our following study. The accumulation and distribution of silver ions in the main organs of rats and their potential toxicity also needed to be evaluated in the future.
Conclusion
SF-AgNPs composite scaffolds loaded with gentamycin were designed to treat MRSA-induced chronic osteomyelitis. The resulting SF-AgNPs composite scaffolds showed good three-dimensional pore structure, uniform distribution of AgNPs, favourable biocompatibility with osteoblast and efficient antibacterial properties against MRSA. In vivo study indicated that the implanting of gentamycinloaded composite scaffolds exhibited superior anti-infection effect, suggesting their potential application in repairing osteomyelitis-related bone defects.
